1/16
06:00 am
tvtx
TVTX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
Low
Report
TVTX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm
1/15
08:14 am
tvtx
Travere Therapeutics 2026 Outlook: Filspari Momentum, FSGS FDA Delay, And Market Potential [Seeking Alpha]
Low
Report
Travere Therapeutics 2026 Outlook: Filspari Momentum, FSGS FDA Delay, And Market Potential [Seeking Alpha]
1/14
05:26 pm
tvtx
Is Travere Therapeutics (TVTX) Pricing Reflect Long Term Value After Recent Share Price Pullback [Yahoo! Finance]
Low
Report
Is Travere Therapeutics (TVTX) Pricing Reflect Long Term Value After Recent Share Price Pullback [Yahoo! Finance]
1/14
04:04 pm
tvtx
INVESTOR ALERT: Investigation of Travere Therapeutics, Inc. (TVTX) by Holzer & Holzer, LLC
Low
Report
INVESTOR ALERT: Investigation of Travere Therapeutics, Inc. (TVTX) by Holzer & Holzer, LLC
1/14
12:13 pm
tvtx
TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA [Yahoo! Finance]
Low
Report
TVTX Stock Falls as FDA Extends Review Timeline for Filspari sNDA [Yahoo! Finance]
1/14
08:42 am
tvtx
Travere Therapeutics (NASDAQ:TVTX) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Travere Therapeutics (NASDAQ:TVTX) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/13
08:21 pm
tvtx
Why Travere Therapeutics Stock Got Trounced on Tuesday [Yahoo! Finance]
Low
Report
Why Travere Therapeutics Stock Got Trounced on Tuesday [Yahoo! Finance]
1/13
06:58 pm
tvtx
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
Low
Report
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
1/13
03:05 pm
tvtx
SHAREHOLDER ALERT: Travere Therapeutics, Inc. Investigated for Securities Fraud by Block & Leviton; Investors Who Lost Money Should Contact The Firm
Medium
Report
SHAREHOLDER ALERT: Travere Therapeutics, Inc. Investigated for Securities Fraud by Block & Leviton; Investors Who Lost Money Should Contact The Firm
1/13
02:19 pm
tvtx
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS [Yahoo! Finance]
Medium
Report
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS [Yahoo! Finance]
1/13
02:18 pm
tvtx
Top Midday Decliners [Yahoo! Finance]
Medium
Report
Top Midday Decliners [Yahoo! Finance]
1/13
01:24 pm
tvtx
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS
High
Report
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS
1/12
05:00 pm
tvtx
Travere Therapeutics Provides Corporate Update and 2026 Outlook
High
Report
Travere Therapeutics Provides Corporate Update and 2026 Outlook
1/5
05:03 pm
tvtx
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
04:30 pm
tvtx
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/26
06:51 am
tvtx
Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesday [Yahoo! Finance]
Low
Report
Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesday [Yahoo! Finance]
12/25
07:00 pm
tvtx
Is Travere Therapeutics Still Attractively Priced After Its 135% Share Price Surge? [Yahoo! Finance]
Low
Report
Is Travere Therapeutics Still Attractively Priced After Its 135% Share Price Surge? [Yahoo! Finance]
12/25
07:00 pm
tvtx
Why Travere Therapeutics (TVTX) Is Up 18.9% After FDA Eases FILSPARI Oversight And Delays Adcom [Yahoo! Finance]
Low
Report
Why Travere Therapeutics (TVTX) Is Up 18.9% After FDA Eases FILSPARI Oversight And Delays Adcom [Yahoo! Finance]
12/25
07:00 pm
tvtx
Travere Therapeutics (TVTX): Valuation Check After FDA Tailwinds and FSGS Expansion Hopes for FILSPARI [Yahoo! Finance]
Low
Report
Travere Therapeutics (TVTX): Valuation Check After FDA Tailwinds and FSGS Expansion Hopes for FILSPARI [Yahoo! Finance]
12/11
05:00 pm
tvtx
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/29
03:35 am
tvtx
Travere Therapeutics (NASDAQ:TVTX) was downgraded by analysts at
Wall St
Low
Report
Travere Therapeutics (NASDAQ:TVTX) was downgraded by analysts at
Wall St
11/28
08:00 am
tvtx
Travere Therapeutics (NASDAQ:TVTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
Medium
Report
Travere Therapeutics (NASDAQ:TVTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $47.00 price target on the stock.
11/26
08:18 am
tvtx
Why IBD 50's No. 3 Stock, Travere Therapeutics, Has Doubled In 2025 [Yahoo! Finance]
Low
Report
Why IBD 50's No. 3 Stock, Travere Therapeutics, Has Doubled In 2025 [Yahoo! Finance]
11/26
07:22 am
tvtx
Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA [Seeking Alpha]
Low
Report
Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA [Seeking Alpha]
11/19
03:00 pm
tvtx
Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally [Yahoo! Finance]
Low
Report
Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally [Yahoo! Finance]